Market Place
Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets. 
X
Please Wait
Applying Filters...
01 Ofichem BV (1)
02 Chattem Chemicals, Inc. (1)
03 W. R. Grace & Co.-Conn. (1)
01 Methenamine Mandelate (3)
01 Netherlands (1)
02 U.S.A (2)
47
PharmaCompass offers a list of Methenamine Mandelate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methenamine Mandelate manufacturer or Methenamine Mandelate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methenamine Mandelate manufacturer or Methenamine Mandelate supplier.
PharmaCompass also assists you with knowing the Methenamine Mandelate API Price utilized in the formulation of products. Methenamine Mandelate API Price is not always fixed or binding as the Methenamine Mandelate Price is obtained through a variety of data sources. The Methenamine Mandelate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate), including repackagers and relabelers. The FDA regulates 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) supplier is an individual or a company that provides 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) active pharmaceutical ingredient (API) or 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) finished formulations upon request. The 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) suppliers may include 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) API manufacturers, exporters, distributors and traders.
click here to find a list of 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) suppliers with NDC on PharmaCompass.
We have 3 companies offering 1,3,5,7-Tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate)
Get in contact with the supplier of your choice:
